Post-stroke treatment with argon attenuated brain injury, reduced brain inflammation and enhanced M2 microglia/macrophage polarization: a randomized controlled animal study.
Jingjin LiuKay NolteGary BrookLisa LiebenstundAgnieszka WeinandyAnke HölligMichael VeldemanAntje WilluweitKarl-Josef LangenRolf RossaintMark CoburnPublished in: Critical care (London, England) (2019)
Argon administration with a 3 h delay after stroke onset and 1 h after reperfusion significantly alleviated neurological deficit within the first week and preserved the neurons at the ischemic boundary zone 7 days after stroke. Moreover, argon reduced the excessive microglia/macrophage activation and promoted the switch of microglia/macrophage polarization towards the anti-inflammatory M2 phenotype. Studies making efforts to further elucidate the protective mechanisms and to benefit the translational application are of great value.
Keyphrases
- cerebral ischemia
- brain injury
- subarachnoid hemorrhage
- inflammatory response
- neuropathic pain
- anti inflammatory
- blood brain barrier
- oxidative stress
- spinal cord
- adipose tissue
- randomized controlled trial
- heart failure
- spinal cord injury
- quality improvement
- white matter
- physical activity
- resting state
- left ventricular
- combination therapy
- percutaneous coronary intervention